I have a small amount of $$ in fidelity's bio tech sector fund. It's tripled in the past three years. can't complain about that.
Now there was someone a couple months ago claiming that bio was going to be the place to be this year. good luck all.
absolutely far out. PFE launches a blockbuster using an AI from ATRS. and buys a company that already has a boatload of prefilled (read approved) syringes mated with drugs. Talk about synergy !!
Now the PPS for ATRS rises, Teva and PFE get into a bidding war...........
How can it be absorbed thru the lymphatic system if it's taken orally ? If it goes thru the gut, it hits the liver first.
oh come'on Nam... that's not what he said at all.
I'll sum it up for you:
"Maybe if people had stuck to the issue instead of carrying out ad-hominem attacks."
There is a category when you complain about a post called "harrasment". so if you do carry out an ad-hominem, you run the risk of getting the post deleted.
The thing I see thou is that china is getting all of it's iron ore from austrailia and at the same time needing less ore.
A combination that will keep the BDI down. even with the internal chinese mines closed.
(Bloomberg) -- Iron ore retreated to the lowest level in more than five years as a slowdown in China hurt the outlook for demand in the world’s biggest user while the largest mining companies add to supply, boosting a surplus.
Ore with 62 percent content delivered to Qingdao, China, tumbled 4.3 percent to $63.54 a dry metric ton, according to data by Metal Bulletin Ltd. That’s the lowest price on record going back to May 2009, and was the biggest one-day fall since Nov. 18. The commodity is 11 percent lower this year.
The raw material has been in a bear market since March after Rio Tinto Group, BHP Billiton Ltd. and Vale SA spent billions of dollars to boost low-cost output even as China slowed. Goldman Sachs Group Inc. joined global banks on Friday in cutting price forecasts for 2015, predicting a return to a bull market is probably more than a decade away. The love affair between China and iron ore is cooling, the bank said.
The decline in prices is mainly due to “slower demand growth for steel in China, together with the expected new iron ore supply,” Vanessa Lau, a Hong Kong-based analyst at Sanford C. Bernstein Ltd., said before the figure was released. Steel mills in China are also cutting output before the Lunar New Year, putting further pressure on prices, she said, referring to the national holiday next month when industrial activity slows.
Gripped by a property downturn and excess capacity, China’s economy expanded 7.4 percent last year, the slowest pace since 1990, data on Tuesday showed. Crude-steel production rose 0.9 percent in 2014 compared with 7.5 percent the previous year
totally w/you on that Andre. The problem is that many people commit the ultimate crime of mindless bashing and mindless pumping. I hate both equally.
Tell me your opinion and back it up with some evidence.... or shut up. Loko does this with great skill. (not shut up, I mean he backs up his assertions. )
a few years ago I was holding this and occasionally traded in / out. I mentioned something about other injectors and got duly assaulted. Not just w/red thumbs but several posts questioning my motives, my character, and how often I get laid.
Not one person said: "hey, lets look at some of those other injectors for a minute".
I checked it out on my own and just didn't bother to share what I found. why should I?
So who's loss was that?
Due to some weather related issues and that my work computer does not let me go to just any site, I did not go to that link.
I have to use my home computer to actually get stuff done like read a link.
(it's a security issue)
it is, indeed, a bad situation. GE got his predictions totally wrong.
I can only hope that other companies are scrapping their fleets so the market balances out eventually.
I think whogo has, in his post, listed the revenue. cut out G&A and cost of sales etc. and you'd probably have about a 1.5 mil profit (after the profit split.)
How the heck did loko find this? flat out amazing!
Thanks to loko for finding this and thank you Nam for posting this.
This kind of read makes my morning.
can't please everyone;
If there was no press release, people like you would complain.
If there is a press release, People like you complain.
Take your pick.
I was looking for the timeframes involved between when the person realizes he/she is having an attack and the time that person has to do the injection. couldn't find that but found some light reading from Wikipedia. JUst some background noise for anyone new here or not familiar with these pens.
The devices contain a spring-loaded needle that exits the tip of the device (in some cases through a sterile membrane) and penetrates the recipient's skin, to deliver the medication via intramuscular injection.
Epinephrine autoinjectors contain a pre-determined dose of epinephrine, usually between 300 μg and 500 μg of active ingredient at a concentration of 1:1000. They typically contain more medication than the amount needed for a single dose, but any extra amount is not intended for use and is inaccessible without destroying the device. Manufacturers have also made pediatric dosed versions available at 150 μg of active ingredient. There was a version that contained two individual doses (in case a repeated application is required) previously sold under the trade name Twinject. The company that produced Twinject autoinjectors, Shionogi, announced that it was discontinuing Twinject effective March 30, 2012.
In 2010, European regulators approved a new epinephrine auto-injector made by ALK and sold under the brand name Jext.  The product was launched in the European Union in September 2011.
On August 13, 2012, the U.S. Food and Drug Administration (FDA) approved a new version of epinephrine auto-injector made by Intelliject and Sanofi called the Auvi-Q. It is rectangular in shape, 3.5 inches by 2 inches by 0.5 inch. It has a soundchip in it to give audio cues to a patient or caregiver to aid in the proper use of the device.
In January 2013, the UK MHRA approved Emerade (from Namtall AB), the first auto-injector fitted with 25mm needles to the 300μg and 500μg models.
In most countries, epinephrine is a prescription drug, and therefore obtaining the device requires a prescription from a doctor. However, in some jurisdictions, epinephrine autoinjectors are an over-the-counter drug and may be purchased from a pharmacy counter.
so in an emergency situatiion:
The subject, once realizing he's having a reaction, has to grab his epi-pen and prepare it for use.
Just how much time from the point of realization to the point when he's passing out or becoming immobile (for the act of using the pen), does the person have?
I'm kinda wondering just how much of an emergency situation this is.
Can't argue against this. Nicely said td.
I suppose the bureaucracy is at fault here. An attempt to slow or stop using the gov't to do it's thing:
Remember how the gov't works. It takes a whole room of people to say yes but it only takes one to say no. The serious: "covering ones #$%$" form of thought in the gov't is at play here. That's what Mylan is counting on.
So we are talking removing a cover on the needle end and then a thumb flip. It would seem obvious that the needle cover has to be removed before use and any one who gets a new drug or a new device (any reasonable person) would investigate how it works and what to do before using it and (any reasonable person) would do this before an emergency happens.